Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure
Author
Abstract
Suggested Citation
DOI: 10.1007/s40273-024-01387-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Patrick W. Sullivan & Vahram Ghushchyan, 2006. "Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States," Medical Decision Making, , vol. 26(4), pages 410-420, July.
- Anthony J. Hatswell & Darren Burns & Gianluca Baio & Frances Wadelin, 2019. "Frequentist and Bayesian meta‐regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 653-665, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Raymond Oppong & Billingsley Kaambwa & Jacqueline Nuttall & Kerenza Hood & Richard Smith & Joanna Coast, 2013. "The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 197-209, April.
- Michael Falk Hvidberg & Mónica Hernández Alava, 2023. "Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA," PharmacoEconomics, Springer, vol. 41(10), pages 1287-1388, October.
- Zlatana Nenova & Jennifer Shang, 2022. "Personalized Chronic Disease Follow‐Up Appointments: Risk‐Stratified Care Through Big Data," Production and Operations Management, Production and Operations Management Society, vol. 31(2), pages 583-606, February.
- Knott, R. & Lorgelly, P. & Black, N. & Hollingsworth, B., 2016. "Differential item functioning in the EQ-5D: An exploratory analysis using anchoring vignettes," Health, Econometrics and Data Group (HEDG) Working Papers 16/14, HEDG, c/o Department of Economics, University of York.
- Alejandro Arrieta & Timothy F Page & Emir Veledar & Khurram Nasir, 2017. "Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-14, January.
- Shan Liu & Michaël Schwarzinger & Fabrice Carrat & Jeremy D Goldhaber-Fiebert, 2011. "Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients," PLOS ONE, Public Library of Science, vol. 6(12), pages 1-14, December.
- Mathieu F. Janssen & A. Simon Pickard & James W. Shaw, 2021. "General population normative data for the EQ-5D-3L in the five largest European economies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(9), pages 1467-1475, December.
- Mehdi Javanbakht & Jesse Fishman & Eoin Moloney & Peter Rydqvist & Amir Ansaripour, 2023. "Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis," PharmacoEconomics - Open, Springer, vol. 7(1), pages 93-110, January.
- Lisa Meckley & James Gudgeon & Jeffrey Anderson & Marc Williams & David Veenstra, 2010. "A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing," PharmacoEconomics, Springer, vol. 28(1), pages 61-74, January.
- Andrew J. Palmer & Julie A. Campbell & Barbara de Graaff & Nancy Devlin & Hasnat Ahmad & Philip M Clarke & Mingsheng Chen & Lei Si, 2021. "Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1950-1977, August.
- C. Simone Sutherland & Pollyanna Hudson & Stephen Mitchell & Noman Paracha, 2022. "Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers," PharmacoEconomics, Springer, vol. 40(1), pages 39-67, April.
- Knott, Rachel J. & Lorgelly, Paula K. & Black, Nicole & Hollingsworth, Bruce, 2017. "Differential item functioning in quality of life measurement: An analysis using anchoring vignettes," Social Science & Medicine, Elsevier, vol. 190(C), pages 247-255.
- Guihua Wang & Jun Li & Wallace J. Hopp & Franco L. Fazzalari & Steven F. Bolling, 2019. "Using Patient-Specific Quality Information to Unlock Hidden Healthcare Capabilities," Manufacturing & Service Operations Management, INFORMS, vol. 21(3), pages 582-601, July.
- Michael Falk Hvidberg & Louise Schouborg Brinth & Anne V Olesen & Karin D Petersen & Lars Ehlers, 2015. "The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-16, July.
- Robinson, Lisa A. & Hammitt, James K., 2013.
"Skills of the trade: valuing health risk reductions in benefit-cost analysis,"
Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 4(1), pages 107-130, March.
- Robinson Lisa A. & Hammitt James K., 2013. "Skills of the trade: valuing health risk reductions in benefit-cost analysis," Journal of Benefit-Cost Analysis, De Gruyter, vol. 4(1), pages 107-130, March.
- Sandra Tunis, 2011. "Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin," Applied Health Economics and Health Policy, Springer, vol. 9(6), pages 351-365, November.
- Jason Shafrin & Jeff Sullivan & Dana P Goldman & Thomas M Gill, 2017. "The association between observed mobility and quality of life in the near elderly," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-13, August.
- Christine McDonough & Anna Tosteson, 2007. "Measuring Preferences for Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 25(2), pages 93-106, February.
- Xinrui Wu & Qian Liu & Qi Li & Zhengwen Tian & Hongzhuan Tan, 2019. "Health-Related Quality of Life and Its Determinants among Criminal Police Officers," IJERPH, MDPI, vol. 16(8), pages 1-12, April.
- Shan Liu & Lauren E Cipriano & Mark Holodniy & Jeremy D Goldhaber-Fiebert, 2013. "Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States," PLOS ONE, Public Library of Science, vol. 8(3), pages 1-14, March.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:42:y:2024:i:7:d:10.1007_s40273-024-01387-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.